Astraveus, the Benchtop Cell Factory company, is excited to welcome seasoned Life Science executive David Newble as new member of its Advisory Board. David held several C-level roles at Life Science technology companies, such as CEO of SPT Labtech and CEO of TAP Biosystems. In this role, David led the development of the AMBR® high-throughput bioreactor, which has become an industry-leading platform for cell culture process development. David played an instrumental role in the acquisition of TAP Biosystems by Sartorius and the successful integration of the AMBR® platform into Sartorius’ portfolio. David also founded Fluidic Sciences, a protein analytics company which he currently serves as Board Director. “It is a privilege to welcome David as member of our Advisory Board. We are very excited to work with David and leverage his outstanding expertise in the bioprocessing ecosystem to support the successful development of the Lakhesys Benchtop Cell FactoryTM” says Dr. Jérémie Laurent, CEO and founder of Astraveus.